Vessi Medical - a novel treatment for Non Muscle Invasive Bladder Cancer (NMIBC). Vessi Medical uses surface cryotherapy, a treatment that utilizes extreme cold, to freeze and destroy abnormal tissue
Location: Israel
Total raised: $18.2M
Investors 1
| Date | Name | Website |
| 09.02.2024 | ALIVE | alivevc.co... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 15.02.2024 | Series A | $16.5M | - |
| 31.08.2020 | - | $1.7M | - |
Mentions in press and media 3
| Date | Title | Description |
| 15.02.2024 | Vessi Medical Closes $16.5M Series A Funding Round | Vessi Medical, a Misgav, Israel-based urology medical device company, raised $16.5M in Series A funding. Backers included ALIVE- Israel HealthTech Fund, and Agriline, which joined The Trendlines Group. The company intends to use the funds t... |
| 31.08.2020 | Vessi Medical Raises $1.7M in Funding | Vessi Medical, a Misgav, Israel-based developer of a cryoablation solution for superficial bladder cancer, secured $1.7m in funding. Participating in the financing were Agriline, The Trendlines Group, the Israel Innovation Authority, and Ex... |
| - | Vessi Medical | “Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).” |